← All companies

CI

The Cigna Group

CI NYSE Hospital & Medical Service Plans EDGAR ↗

$282.06

+3.01 +1.08%

Key statistics

from XBRL data in SEC filings

Market cap

$74.5B

Revenue (TTM)

$282B

Net income (TTM)

$6.42B

EPS (TTM)

$24.17

P/E ratio

11.7

Dividend yield

2.18%

Free cash flow

$8.55B

Cash

$6.30B

Total assets

$157B

Gross margin

—

52-week range

$239.51 – $315.47

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Regulation FD disclosure May 13, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Shareholder vote results Apr 27, 2026 8-K Director or officer change; Regulation FD disclosure Mar 3, 2026 8-K Regulation FD disclosure Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 5, 2026 8-K Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Director or officer change Oct 20, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Sep 4, 2025 8-K Regulation FD disclosure Sep 2, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K/A Director or officer change Jul 28, 2025 8-K Director or officer change Jun 2, 2025 8-K Regulation FD disclosure May 20, 2025 10-Q Quarter ended 2025-03-31 May 2, 2025 8-K Results of operations (earnings release) May 2, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Director or officer change; Shareholder vote results Apr 28, 2025 8-K Director or officer change Apr 18, 2025 8-K Other events Mar 19, 2025 8-K Director or officer change; Regulation FD disclosure Mar 13, 2025 8-K Regulation FD disclosure Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Jan 30, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K Regulation FD disclosure Sep 3, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change Jun 20, 2024 8-K Regulation FD disclosure Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Shareholder vote results Apr 26, 2024